SCHEMBL31279012

SCHEMBL31279012

O=C1CCN(N2Cc3cc(CN4CCN(c5ccnc(Cl)c5Cl)CC4)ccc3C2=O)C(=O)N1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 8/20 0.40
CRBN Q96SW2 6/20 0.36
IKZF3 Q9UKT9 5/20 0.36
HTR1A P08908 5/20 0.35
HTR2A P28223 5/20 0.35
DRD4 P21917 2/20 0.35
HTR2C P28335 2/20 0.35
DRD3 P35462 2/20 0.35
DRD1 P21728 1/20 0.35
DRD5 P21918 1/20 0.35
HTR2B P41595 1/20 0.35
IKZF2 Q9UKS7 4/20 0.35
ALDH1A1 P00352 1/20 0.35
DDB1 Q16531 5/20 0.34
SLC6A4 P31645 1/20 0.34
HTR7 P34969 1/20 0.34
METTL3 Q86U44 1/20 0.34
ADRA1D P25100 1/20 0.34
ADRA1A P35348 1/20 0.34
ADRA1B P35368 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31280317 0.91 DRD2 (0.35) DRD2CRBNIKZF3HTR1AHTR2A
SCHEMBL31278698 0.91 CRBN (0.37) DRD2CRBNIKZF3HTR1AHTR2A
SCHEMBL31280244 0.88 DRD2 (0.37) DRD2CRBNIKZF3HTR1AHTR2A
SCHEMBL31278518 0.87 ALDH1A1 (0.38) DRD2CRBNIKZF3HTR1AHTR2A
SCHEMBL31279743 0.86 LMNA (0.37) DRD2HTR1AHTR2ADRD4DRD3
SCHEMBL31279168 0.86 DRD2 (0.39) DRD2CRBNIKZF3DRD4DRD3
SCHEMBL31279051 0.86 IKZF2 (0.36) DRD2CRBNIKZF3HTR1AHTR2A
SCHEMBL31279424 0.86 DRD2 (0.38) DRD2CRBNIKZF3HTR1AHTR2A
SCHEMBL31280037 0.85 DRD2 (0.55) DRD2HTR1AHTR2ADRD4HTR2C
SCHEMBL31279771 0.85 DRD2 (0.39) DRD2CRBNIKZF3HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722207-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-04-08 EP claimed
WO-2024245444-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-12-05 WO claimed
EP-4722207-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF Gluetacs Therapeutics (Shanghai) Co., Ltd. (CN) 2026-04-08 EP disclosed
WO-2024245444-A1 OXOISOINDOLINYL-SUBSTITUTED TETRAHYDROPYRIMIDINEDIONE DERIVATIVE AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-12-05 WO disclosed